Suboj Babykutty

Suboj Babykutty

Auto-generated profile, based on publicly available information

Suboj Babykutty

Department of Biochemistry, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, Kerala, India

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2011 in Molecular Carcinogenesis
Verified
Journal Article
Open access
PDF file
SBSuboj Babykutty
Suboj Babykutty
PPPriya P.S.
Priya P.S.
NRNandini R.J.
Nandini R.J.
MKM.A. Suresh Kumar
M.A. Suresh Kumar
MNMangalam S. Nair
Mangalam S. Nair
SGSrinivas Gopala
Srinivas Gopala
Nimbolide, a plant‐derived limonoid has been shown to exert its antiproliferative effects in various cell lines. We demonstrate that nimbolide effectively inhibited proliferation of WiDr colon cancer cells through inhibition of cyclin A leading to S phase arrest. It also caused activation of caspase‐mediated apoptosis through the inhibition of ERK1/2 and activation of p38 and JNK1/2. Further nimbolide effectively retarded tumor cell migration and invasion through inhibition of metalloproteinase‐2/9 (MMP‐2/9) expression, both at the mRNA and protein level. It was also a strong inhibitor of VEGF expression, promoter activity, and in vitro angiogenesis. Finally, nimbolide suppressed the nuclear translocation of p65/p50 and DNA binding of NF‐κB, which is an important transcription factor for controlling MMP‐2/9 and VEGF gene expression.